Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
State Board of Pharmacy proposes schedule updates to add fentanyl analogues, synthetic cannabinoids and an exception for an FDA‑approved psilocybin drug
Summary
The State Board of Pharmacy asked the Senate Judiciary Committee to update state controlled‑substances schedules to include newly identified fentanyl analogues, synthetic cannabinoids and other designer drugs, and to provide an exception for an FDA‑approved psilocybin medicine.
The Senate Judiciary Committee heard testimony on Senate Bill 2064 from Mark Hardy, executive director of the North Dakota State Board of Pharmacy, who asked lawmakers to update the state’s controlled‑substances lists to reflect recent federal scheduling actions and to add several newly identified synthetic compounds.
Hardy said the bill mirrors a series of DEA scheduling notices that added…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
